Intrinsic Value

Sage Therapeutics, Inc. (SAGE)

$13.94

+0.83 (+6.37%)

Enterprise Value -7,153,619,137,376.09
Net Debt -65.83
Equity Value -7,153,619,137,310.27
Shares Outstanding 59.84
Equity Value Per Share -119,552,884,793.24



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt